Avalo Therapeutics Ord shares owned by UBS Group
Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Avalo Therapeutics Ord
Tip: Access up to 7 years of quarterly data
All positions including Avalo Therapeutics Ord held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avalo Therapeutics Ord by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $565k | 45k | 12.50 |
| 2025-06-30 | $419k | 84k | 5.00 |
| 2025-03-31 | $792k | 99k | 8.00 |
| 2024-12-31 | $732k | 99k | 7.43 |
| 2024-09-30 | $58k | 6.1k | 9.50 |
| 2024-06-30 | $45k | 3.6k | 12.50 |
| 2024-03-31 | $170k | 7.7k | 22.00 |
| 2023-12-31 | $18 | 2 | 9.00 |